サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1620131

皮下ドラッグデリバリーデバイスの世界市場レポート 2024年

Subcutaneous Drug Delivery Devices Global Market Report 2024

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
皮下ドラッグデリバリーデバイスの世界市場レポート 2024年
出版日: 2024年12月20日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

皮下ドラッグデリバリーデバイス市場規模は、今後数年間で力強い成長が見込まれます。2028年には複合年間成長率（CAGR）7.5％で368億9,000万米ドルに成長します。予測期間に予測される成長は、生物製剤とバイオシミラー市場の拡大、ウェアラブルドラッグデリバリーシステムの採用拡大、個別化医療の成長、医療償還施策の改善、在宅医療の重視の高まりに起因すると考えられます。今後予想される主要動向としては、デジタルヘルス技術の統合、スマートデバイスやコネクテッドデバイスの開発、低侵襲手術の増加、無針注射システムの進歩、デバイス開発における人工知能の台頭などが挙げられます。

糖尿病と心血管疾患（CVD）の有病率の増加は、皮下ドラッグデリバリーデバイス市場の拡大を促進すると予想されます。これらの疾患の増加は、人口の高齢化、食生活の乱れ、座りがちなライフスタイル、肥満、社会経済格差、ストレス、環境要因、予防医療へのアクセス制限などが主要原因となっています。皮下ドラッグデリバリーデバイスは、血糖コントロールのためにインスリンやその他の薬剤を投与する糖尿病管理や、抗凝固剤や脂質低下剤のような薬剤を投与するCVDに広く使用されており、これらの慢性疾患を管理するための便利で管理された方法を提供しています。例えば、英国を拠点とする慈善団体である英国糖尿病協会は2023年4月、英国では現在430万人が糖尿病を患っており、2020～2022年にかけて新規診断者が14万8,951人増加すると報告しました。さらに、英国では240万人以上が2型糖尿病を発症するリスクが高いです。さらに2024年5月、米国の疾病対策予防センター（CDC）は、2022年の心臓病による死亡者数が70万2,880人で、死亡者数の5人に1人を占めていることを明らかにしました。その結果、糖尿病と心血管疾患の有病率の上昇が皮下ドラッグデリバリーデバイス市場の成長を促進しています。

皮下ドラッグデリバリーデバイス市場の主要参入企業は、薬剤送達の安全性と精度を向上させるため、小型デジタル液体流量センサーのような先進製品の開発に注力しています。これらのセンサーは液体の流量を正確に測定することができ、特に大容量の注入器に有用です。例えば、2024年 5月、スイスを拠点とする環境・流量センサのプロバイダであるSensirion AGは、SLD3xシリーズセンサプラットフォームを発表しました。このシリーズには、カスタマイズ可能な機能を備えた高精度デジタル液体流量センサが含まれ、正確な流量測定、閉塞検出、気泡識別、液体温度モニタリングが可能です。これらの小型センサーは大規模な医療機器製造に適しており、皮下ドラッグデリバリーにおける最適な投与と患者の安全性向上を保証します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の市場規模と成長

  • 世界の皮下ドラッグデリバリーデバイス市場：促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の皮下ドラッグデリバリーデバイス市場の実績：規模と成長、2018～2023年
  • 世界の皮下ドラッグデリバリーデバイス市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の皮下ドラッグデリバリーデバイス市場：製品タイプ別、実績と予測、2018～2023年、2023～2028年、2033年
  • インスリンペン
  • ペン針
  • 注射ペン
  • 自動注射器
  • 埋め込み型ポンプ
  • 世界の皮下ドラッグデリバリーデバイス市場：用途別、実績と予測、2018～2023年、2023～2028年、2033年
  • 糖尿病
  • 生殖能力
  • 腫瘍学
  • 世界の皮下ドラッグデリバリーデバイス市場：エンドユーザー別、実績と予測、2018～2023年、2023～2028年、2033年
  • 病院とクリニック
  • 在宅医療
  • 外来手術センター

第7章 地域別・国別分析

  • 世界の皮下ドラッグデリバリーデバイス市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の皮下ドラッグデリバリーデバイス市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 皮下ドラッグデリバリーデバイス市場：競合情勢
  • 皮下ドラッグデリバリーデバイス市場：企業プロファイル
    • Pfizer Inc.
    • Sanofi S.A.
    • Roche Holdings Inc.
    • Medtronic plc
    • Eli Lilly and Company

第31章 その他の大手企業と革新的企業

  • Amgen Inc.
  • Novo Nordisk A/S
  • Becton Dickinson and Company
  • West Pharmaceutical Services Inc.
  • Gerresheimer AG
  • Insulet Corporation
  • SHL Medical AG
  • Tandem Diabetes Care Inc.
  • Ypsomed Holding AG
  • Nemera
  • Elcam Medical Ltd.
  • Owen Mumford Ltd.
  • Haselmeier GmbH
  • Sensile Medical AG
  • Enable Injections Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

目次
Product Code: r20878

Subcutaneous drug delivery devices are medical devices designed to administer medications directly into the subcutaneous tissue, which is the layer of fat and connective tissue just beneath the skin. These devices are employed for delivering various drugs, including insulin, hormones, and biologics, offering a convenient and minimally invasive method of administration.

The main types of subcutaneous drug delivery devices include insulin pens, pen needles, injector pens, auto-injectors, and implantable pumps. Insulin pens are handheld devices used for precise and convenient insulin administration in diabetes management, enabling users to easily measure and inject doses. These devices are used in various applications, such as diabetes, fertility, and oncology, and are utilized by different end-users, including hospitals, clinics, homecare settings, and ambulatory surgical centers.

The subcutaneous drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides subcutaneous drug delivery devices market statistics, including subcutaneous drug delivery devices industry global market size, regional shares, competitors with a subcutaneous drug delivery devices market share, detailed subcutaneous drug delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the subcutaneous drug delivery devices industry. This subcutaneous drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The subcutaneous drug delivery devices market size has grown strongly in recent years. It will grow from $25.78 billion in 2023 to $27.66 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases, a growing demand for self-administration of drugs, rising rates of diabetes and obesity, patient preference for convenient treatments, and the expanding geriatric population.

The subcutaneous drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $36.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. The growth projected for the forecast period can be attributed to the expansion of the biologics and biosimilars market, increasing adoption of wearable drug delivery systems, the growth of personalized medicine, improvements in healthcare reimbursement policies, and a growing emphasis on home healthcare. Key trends expected include the integration of digital health technologies, the development of smart and connected devices, a rise in minimally invasive procedures, advancements in needle-free injection systems, and the emergence of artificial intelligence in device development.

The growing prevalence of diabetes and cardiovascular diseases (CVD) is expected to drive the expansion of the subcutaneous drug delivery devices market. The rise in these conditions is largely due to aging populations, poor diets, sedentary lifestyles, obesity, socioeconomic disparities, stress, environmental factors, and limited access to preventive healthcare. Subcutaneous drug delivery devices are widely used in diabetes management to administer insulin and other medications for glycemic control, as well as in CVD to deliver drugs like anticoagulants or lipid-lowering agents, offering a convenient and controlled way to manage these chronic diseases. For example, in April 2023, the British Diabetic Association, a UK-based charity, reported that 4.3 million people in the UK are currently living with diabetes, with new diagnoses increasing by 148,951 from 2020-21 to 2021-22. Additionally, over 2.4 million people in the UK are at high risk of developing type 2 diabetes. Furthermore, in May 2024, the Centers for Disease Control and Prevention (CDC) in the U.S. revealed that heart disease caused 702,880 deaths in 2022, accounting for 1 in every 5 deaths. As a result, the rising prevalence of diabetes and cardiovascular diseases is driving the growth of the subcutaneous drug delivery devices market.

Key players in the subcutaneous drug delivery device market are concentrating on developing advanced products such as miniature digital liquid flow sensors to improve the safety and accuracy of drug delivery. These sensors provide precise measurements of liquid flow rates and are especially useful for large-volume injectors. For instance, in May 2024, Sensirion AG, a Switzerland-based provider of environmental and flow sensors, introduced the SLD3x series sensor platform. This series includes highly accurate digital liquid flow sensors with customizable features, enabling precise flow measurement, occlusion detection, air bubble identification, and liquid temperature monitoring. These miniature sensors are suitable for large-scale medical device production, ensuring optimal dosing and enhanced patient safety in subcutaneous drug delivery.

In May 2022, Halozyme Therapeutics Inc., a US-based biopharmaceutical company, acquired Antares Pharma Inc. for $0.960 billion. This acquisition aims to enhance Halozyme's biopharmaceutical capabilities by incorporating Antares' innovative drug delivery technologies and expanding its portfolio. The goal is to improve patient outcomes and accelerate the global development of Halozyme's ENHANZE technology. Antares Pharma Inc., also based in the US, specializes in subcutaneous drug delivery devices.

Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.

North America was the largest region in the subcutaneous drug delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the subcutaneous drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The subcutaneous drug delivery devices market consists of sales of needles, cartridges, and reservoirs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Subcutaneous Drug Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on subcutaneous drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for subcutaneous drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The subcutaneous drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Insulin Pens; Pen Needles; Injector Pens; Auto-Injectors; Implantable Pumps
  • 2) By Application: Diabetes; Fertility; Oncology
  • 3) By End-User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers
  • Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Roche Holdings Inc.; Medtronic plc; Eli Lilly and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Subcutaneous Drug Delivery Devices Market Characteristics

3. Subcutaneous Drug Delivery Devices Market Trends And Strategies

4. Subcutaneous Drug Delivery Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Subcutaneous Drug Delivery Devices Market Size and Growth

  • 5.1. Global Subcutaneous Drug Delivery Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Subcutaneous Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Subcutaneous Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Subcutaneous Drug Delivery Devices Market Segmentation

  • 6.1. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Insulin Pens
  • Pen Needles
  • Injector Pens
  • Auto-Injectors
  • Implantable Pumps
  • 6.2. Global Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Diabetes
  • Fertility
  • Oncology
  • 6.3. Global Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers

7. Subcutaneous Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Subcutaneous Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Subcutaneous Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Subcutaneous Drug Delivery Devices Market

  • 8.1. Asia-Pacific Subcutaneous Drug Delivery Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Subcutaneous Drug Delivery Devices Market

  • 9.1. China Subcutaneous Drug Delivery Devices Market Overview
  • 9.2. China Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Subcutaneous Drug Delivery Devices Market

  • 10.1. India Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Subcutaneous Drug Delivery Devices Market

  • 11.1. Japan Subcutaneous Drug Delivery Devices Market Overview
  • 11.2. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Subcutaneous Drug Delivery Devices Market

  • 12.1. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Subcutaneous Drug Delivery Devices Market

  • 13.1. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Subcutaneous Drug Delivery Devices Market

  • 14.1. South Korea Subcutaneous Drug Delivery Devices Market Overview
  • 14.2. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Subcutaneous Drug Delivery Devices Market

  • 15.1. Western Europe Subcutaneous Drug Delivery Devices Market Overview
  • 15.2. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Subcutaneous Drug Delivery Devices Market

  • 16.1. UK Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Subcutaneous Drug Delivery Devices Market

  • 17.1. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Subcutaneous Drug Delivery Devices Market

  • 18.1. France Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Subcutaneous Drug Delivery Devices Market

  • 19.1. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Subcutaneous Drug Delivery Devices Market

  • 20.1. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Subcutaneous Drug Delivery Devices Market

  • 21.1. Eastern Europe Subcutaneous Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Subcutaneous Drug Delivery Devices Market

  • 22.1. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Subcutaneous Drug Delivery Devices Market

  • 23.1. North America Subcutaneous Drug Delivery Devices Market Overview
  • 23.2. North America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Subcutaneous Drug Delivery Devices Market

  • 24.1. USA Subcutaneous Drug Delivery Devices Market Overview
  • 24.2. USA Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Subcutaneous Drug Delivery Devices Market

  • 25.1. Canada Subcutaneous Drug Delivery Devices Market Overview
  • 25.2. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Subcutaneous Drug Delivery Devices Market

  • 26.1. South America Subcutaneous Drug Delivery Devices Market Overview
  • 26.2. South America Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Subcutaneous Drug Delivery Devices Market

  • 27.1. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Subcutaneous Drug Delivery Devices Market

  • 28.1. Middle East Subcutaneous Drug Delivery Devices Market Overview
  • 28.2. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Subcutaneous Drug Delivery Devices Market

  • 29.1. Africa Subcutaneous Drug Delivery Devices Market Overview
  • 29.2. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Subcutaneous Drug Delivery Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Subcutaneous Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Subcutaneous Drug Delivery Devices Market Competitive Landscape
  • 30.2. Subcutaneous Drug Delivery Devices Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Sanofi S.A.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Roche Holdings Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Medtronic plc
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Eli Lilly and Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Subcutaneous Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Amgen Inc.
  • 31.2. Novo Nordisk A/S
  • 31.3. Becton Dickinson and Company
  • 31.4. West Pharmaceutical Services Inc.
  • 31.5. Gerresheimer AG
  • 31.6. Insulet Corporation
  • 31.7. SHL Medical AG
  • 31.8. Tandem Diabetes Care Inc.
  • 31.9. Ypsomed Holding AG
  • 31.10. Nemera
  • 31.11. Elcam Medical Ltd.
  • 31.12. Owen Mumford Ltd.
  • 31.13. Haselmeier GmbH
  • 31.14. Sensile Medical AG
  • 31.15. Enable Injections Inc.

32. Global Subcutaneous Drug Delivery Devices Market Competitive Benchmarking

33. Global Subcutaneous Drug Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Subcutaneous Drug Delivery Devices Market

35. Subcutaneous Drug Delivery Devices Market Future Outlook and Potential Analysis

  • 35.1 Subcutaneous Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Subcutaneous Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Subcutaneous Drug Delivery Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer